Viewing nowCombinationBitorin Table 10/10
Simvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.

MFDS item code 200511262 · Approved 2005.01.31 · Insurance code 073100120
Improvement of hypercholesterolemia (primary or homozygous familial) and mixed hyperlipidemia
This medication helps lower elevated total cholesterol, LDL-cholesterol, apoB protein, and triglyceride levels in patients with primary hypercholesterolemia or mixed hyperlipidemia, and raises good cholesterol levels such as HDL-cholesterol. It is particularly used in conjunction with or as an alternative to other treatments in patients with homozygous familial hypercholesterolemia, and should be taken alongside appropriate dietary regimens to reduce the risk of atherosclerotic vascular disease. It is important to check for other causes, such as diabetes and hypothyroidism, before use and to conduct necessary treatments simultaneously. This medication is used as an adjunctive therapy when dietary and non-pharmacological measures are insufficient, and lipid levels should be continuously monitored for patient safety. In this way, this medication is used to manage hyperlipidemia and improve the risk of cardiovascular disease.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, the recommended treatment goal, and the patient's response. This medicine is administered once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. For patients who require less LDL cholesterol reduction, treatment may be started at 10/10mg daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of 4 weeks or longer and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have been taking 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary for patients with mild hepatic impairment; however, administration of this medicine is not recommended for patients with moderate or severe hepatic impairment (see the section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Exercise caution and carefully monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary when administering this medicine to elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.
This medication is primarily used to lower blood cholesterol levels. Caution is required as muscle issues may arise when taking this medication. If muscle pain or weakness occurs, consult a physician immediately. Patients with impaired liver function or active liver disease should not use this medication. Pregnant or breastfeeding women should not take this medication as it may be harmful to the fetus or infant. Due to potential drug interactions, especially with certain antifungals, antibiotics, immunosuppressants, and some heart medications, it is essential to consult a physician when taking this medication with other drugs. This medication contains lactose, so those with lactose intolerance should avoid taking it. Elderly patients and children under 10 years of age are not recommended to use it, and adolescents over 10 years should take it under the guidance of a physician. It is advisable to undergo regular liver function tests and muscle-related tests during the course of this medication. There is no specific antidote for overdose; if suspected, seek medical treatment immediately. If unexplained muscle pain, muscle weakness, or changes in urine color occur while taking this medication, inform healthcare personnel immediately. This medication may slightly raise blood sugar levels, so patients at risk of diabetes should manage their blood sugar carefully. Exercise caution when taking this medication with certain foods like grapefruit juice, as it may increase drug concentration and the risk of side effects.
Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver amino transferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, sensory disturbances, depression, cholelithiasis, cholecystitis, skin and mucous membrane syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms associated with drug reactions, erythema multiforme, myasthenia, cataracts, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, immune-mediated necrotizing myopathy, dysgeusia, extraocular muscle movement disorders, facial incomplete paralysis, tremor, peripheral neuropathy, peripheral nerve paralysis, mental disorders, anxiety, sleep disorders, memory impairment, forgetfulness, amnesia, memory dysfunction, confusion, interstitial lung disease, lupus erythematosus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibodies, increased erythrocyte sedimentation rate, arthritis, fever, chills, flushing, malaise, dyspnea, cholestatic jaundice, liver fat changes, cirrhosis, fulminant liver necrosis, liver cancer, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ocular muscle paralysis, anemia, elevated amino transferases, elevated ALP, elevated γ-GT, elevated bilirubin levels, thyroid dysfunction, elevated serum creatine kinase, abnormal liver function tests, increased HbA1c, elevated fasting blood glucose levels, edema, thirst, facial edema, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and humidity, so it should be stored in a sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the medication's effectiveness over time.
A capsule-shaped tablet with a white to off-white color, marked with '311' on one side and convex on both sides
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.